European Society of Cardiology (ESC)

This page includes news from the European Society of Cardiology (ESC). The ESC represents more than 95,000 men and women in the field of cardiology from Europe, the Mediterranean basin. It is the European umbrella cardiology organization, which includes the European Association of Percutaneous Cardiovascular Interventions (EAPCI), which hosts the large EuroPCR meeting; the European Heart Rhythm Society (EHRA); European Association of Cardiovascular Imaging (EACVI); European Association of Preventive Cardiology (EAPC); and the Association for Acute Cardiovascular Care (ACVC).

RSS icon
Thumbnail

Foot doctors ID undiagnosed atrial fibrillation in patients with diabetes

Overall, the researchers found, 17% of study participants had undiagnosed AFib.

Thumbnail

Marijuana users with heart rhythm issues risk a ‘devastating outcome’

Marijuana users with a cardiac arrhythmia may face a heightened risk of in-hospital mortality, new research suggests. 

Thumbnail

Red meat linked to heart damage—expert says it ‘seems sensible’ to limit intake

Researchers relied on imaging data from nearly 20,000 UK Biobank participants to reach their conclusion.

Thumbnail

New guidelines focus on the management of heart failure patients with secondary mitral regurgitation

The Heart Failure Association, European Association of Cardiovascular Imaging, European Heart Rhythm Association and European Association of Percutaneous Cardiovascular Interventions all collaborated on the position statement.

Thumbnail

Heart attacks more likely to be missed in women than men

When treating female patients, researchers explained, physicians are less likely to think there is potential for a heart attack.

Thumbnail

A winning strategy for blood transfusions among anemic heart attack patients

Researchers detailed a method that improves patient safety and leads to significant cost savings.

Confirmed: Key heart medications safe to use for COVID-19 patients

The BRACE CORONA trial focused on the safety of taking angiotensin-converting enzyme inhibitors and angiotensin receptor blockers when hospitalized with COVID-19.

Thumbnail

Why early rhythm control therapy is so important for atrial fibrillation patients

The research team's findings were presented at ESC Congress 2020 and published in the New England Journal of Medicine.

Displaying 73 - 80 of 87

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Design by Adaptive Theme
Trimed Popup
Trimed Popup